Form 4 for ESAB ESAB Corp
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001877322-25-000108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-14 | 2025-05-12 | ESAB | Biebuyck Olivier | Pres, Fab Tech | S - Sale+OE | $131.15 | -1,417 | 15.0K | -9% | -$185.8K |
| DM | 2025-05-14 | 2025-05-12 | ESAB | Biebuyck Olivier | Pres, Fab Tech | M - OptEx | $46.94 | +7,743 | 11.7K | +195% | +$363.5K |
| DM | 2025-05-14 | 2025-05-12 | ESAB | Biebuyck Olivier | Pres, Fab Tech | F - Tax | $129.65 | -9,135 | 10.5K | -46% | -$1.18M |
| D | 2025-05-14 | 2025-05-12 | ESAB | Biebuyck Olivier | Pres, Fab Tech | A - Grant | — | +8,922 | 19.5K | +85% | — |
| DM | 2025-05-14 | 2025-05-12 | ESAB | Biebuyck Olivier | Pres, Fab Tech | M - OptEx | $0.00 | -7,743 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2025-05-12 | S | D | 1,417 | $131.15 | 14,989 | D | — | — | |
| 2 | Common | Common stock, par value $0.001 | 2025-05-12 | M | A | 969 | — | 9,845 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. |
| 3 | Common | Common stock, par value $0.001 | 2025-05-12 | F | D | 4,470 | $128.66 | 14,989 | D | — | — | (F4) Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of performance-based restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| 4 | Common | Common stock, par value $0.001 | 2025-05-12 | M | A | 4,413 | $46.94 | 19,402 | D | — | — | |
| 5 | Common | Common stock, par value $0.001 | 2025-05-12 | F | D | 2,996 | $131.67 | 16,406 | D | — | — | (F5) Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the tax liability and exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or this tax liability. |
| 6 | Common | Common stock, par value $0.001 | 2025-05-12 | F | D | 486 | $128.66 | 9,359 | D | — | — | (F2) Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| 7 | Common | Common stock, par value $0.001 | 2025-05-12 | M | A | 2,361 | — | 11,720 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. |
| 8 | Common | Common stock, par value $0.001 | 2025-05-12 | F | D | 1,183 | $128.66 | 10,537 | D | — | — | (F2) Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| 9 | Common | Common stock, par value $0.001 | 2025-05-12 | A | A | 8,922 | — | 19,459 | D | — | — | (F3) Represents shares vested pursuant to performance-based restricted stock units granted on May 12, 2022, which vesting was subject to the certification of certain performance criteria. The award vested on May 12, 2025. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2025-05-12 | M | D | 4,413 | $0.00 | 4,413 | D | $46.94 · 2023-02-24 to 2027-02-23 | 4,413 Common stock, par value $0.001 | (F9) This award represents options that vested in three equal annual installments beginning on the first anniversary of the grant date. 7,334 options were fully vested and exercisable as of the date of ESAB Corporation's separation from Colfax Corporation. All remaining options became fully vested and exercisable on February 24, 2023. |
| 11 | Derivative | Restricted Stock Units | 2025-05-12 | M | D | 2,361 | $0.00 | 4,724 | D | — · 2025-05-12 to 2027-05-12 | 2,361 Common stock, par value $0.001 | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. (F8) This award represents restricted stock units that vest in three equal annual installments beginning on the third anniversary of the grant date. The remaining restricted stock units from this award will vest in two equal tranches on May 12, 2026 and May 12, 2027. |
| 12 | Derivative | Restricted Stock Units | 2025-05-12 | M | D | 969 | $0.00 | 0 | D | — · 2023-05-12 to 2025-05-12 | 969 Common stock, par value $0.001 | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. (F7) This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on May 12, 2025. |